Sana Biotechnology SANA

$ 2.4 -5.34%

Quarterly report 2024-Q3
added 11-08-2024

Sana Biotechnology Financial Statements 2011-2024 | SANA

Annual Financial Statements Sana Biotechnology

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	1.97 B	614 M	1.46 B	42.4 M	-	-	-	-	-	-	-	-	-
Shares	195 M	188 M	166 M	13 M	-	-	-	-	-	-	-	-	-
Historical Prices	10.1	3.26	8.76	-	-	-	-	-	-	-	-	-	-
Net Income	-283 M	-269 M	-356 M	-285 M	-131 M	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-293 M	-273 M	-357 M	-286 M	-141 M	-	-	-	-	-	-	-	-
Interest Expense	-52 K	-674 K	305 K	97 K	-29 K	-	-	-	-	-	-	-	-
EBITDA	-269 M	-257 M	-346 M	-280 M	-139 M	-	-	-	-	-	-	-	-
Operating Expenses	293 M	273 M	357 M	286 M	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	73.3 M	71.6 M	50.4 M	28.3 M	21.8 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Sana Biotechnology

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	235 M	234 M	217 M	198 M	197 M	193 M	191 M	191 M	189 M	188 M	186 M	185 M	182 M	180 M	119 M	16.2 M	13.7 M	12.2 M	10.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-59.9 M	-50.3 M	-107 M	-	984 K	-114 M	-82.1 M	-	-85.1 M	-72.5 M	-31.4 M	-	-83.3 M	18.7 M	-181 M	-	-51.5 M	-87.8 M	-32.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-61.8 M	-49.4 M	-111 M	-	-2.18 M	-116 M	-84.1 M	-	-86.2 M	-72.9 M	-31.7 M	-	-83.4 M	18.6 M	-181 M	-	-51.6 M	-87.9 M	-33.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-742 K	-4.12 M	215 K	-	303 K	-84 K	-47 K	-	-106 K	-198 K	-102 K	-	10 K	1 K	13 K	-	44 K	19 K	5 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-57.7 M	-45.5 M	-107 M	-	2.32 M	-112 M	-79.8 M	-	-82.2 M	-69.1 M	-28.1 M	-	-80.6 M	21.2 M	-179 M	-	-50 M	-86.5 M	-32 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	61.8 M	49.4 M	111 M	-	2.18 M	116 M	84.1 M	-	86.2 M	72.9 M	31.7 M	-	83.4 M	-	181 M	-	51.6 M	-	33.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	14.1 M	16.4 M	16.3 M	-	19.2 M	16.6 M	16.8 M	-	15.5 M	18.3 M	14.4 M	-	13.4 M	12.5 M	11.8 M	-	7.1 M	6.01 M	5.96 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency